| Shelbi Ballard, RN | |
|
604 S Walnut St, Stillwater, OK 74074-4222 | |
| (405) 372-2202 | |
| Not Available |
| Full Name | Shelbi Ballard |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 604 S Walnut St, Stillwater, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033798103 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | R0132900 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shelbi Ballard, RN 604 S Walnut St, Stillwater, OK 74074-4222 Ph: (405) 372-2202 | Shelbi Ballard, RN 604 S Walnut St, Stillwater, OK 74074-4222 Ph: (405) 372-2202 |
News Archive
High living standards and the life style connected to them seem to promote the development of autoimmune diseases and allergic symptoms. This has lead to the assumption that the immune system begins to overreact to the organism's own structures or to exogenous non-infectious proteins, i.e. allergens, when it does not have to work hard enough to protect the individual from infections.
A new study from the Abramson Cancer Center and Department of Psychiatry in the University of Pennsylvania School of Medicine shows that smokers who carry a particular version of a gene for an enzyme that regulates dopamine in the brain may suffer from concentration problems and other cognitive deficits when abstaining from nicotine - a problem that puts them at risk for relapse during attempts to quit smoking.
Secretary of Health Dr. Karen Murphy is reminding Pennsylvanians that June 27 is National HIV Testing Day and urges all Pennsylvanians to get tested for HIV as part of their routine health care.
A recent study published online in the Journal of Molecular Diagnostics demonstrated that Droplet Digital PCR technology can be used to detect mutations in a region of our DNA that is linked to many cancer types, paving the way for the development of new cancer diagnostics and therapies.
4SC AG, a drug discovery and development company, today announced that the first patient has been dosed in the Phase I/II SHORE study with the oral pan-histone deacetylase (HDAC) inhibitor resminostat as a second-line treatment for patients with advanced and metastatic colorectal KRAS-mutant cancer.
› Verified 5 days ago
Ms. Marietta Paulette Sousis, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2322 W 7th Ave, Stillwater, OK 74074 Phone: 405-372-1131 Fax: 405-372-3632 | |
Mr. Jill Renae Jordan, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 604 S Walnut St, Stillwater, OK 74074 Phone: 405-372-2202 Fax: 405-445-3780 | |
Amanda Dawn Rilee, BSN, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 604 S Walnut St, Stillwater, OK 74074 Phone: 405-372-2202 Fax: 405-445-3780 | |
Gina Marie Agnew, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 604 S Walnut St, Stillwater, OK 74074 Phone: 405-372-2202 Fax: 405-445-3780 | |
Tina Marie Ensign, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1624 Cimarron Plz, Stillwater, OK 74075 Phone: 405-372-2202 | |
Sherry Yvette Stout, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1624 Cimarron Plz, Stillwater, OK 74075 Phone: 405-372-2202 Fax: 405-372-2237 |